Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MRTX | AMGN | VRTX | BMY | REGN |
| Company | Mirati Therapeutics | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 58.86 | 313.39 | 401.50 | 43.90 | 926.94 |
| High | 58.99 | 322.60 | 405.67 | 44.33 | 954.10 |
| Low | 58.54 | 310.65 | 397.59 | 43.69 | 926.94 |
| Last | 58.70 | 309.15 | 402.10 | 43.85 | 954.47 |
| Change | -0.10 | +30.76 | +1.94 | +0.15 | +16.86 |
| % Change | -0.17% | +11.05% | +0.48% | +0.34% | +1.80% |
| Volume | 20,994,400 | 7,428,310 | 566,037 | 7,375,695 | 254,436 |
| 20-Day Average Volume | 2,385,220 | 2,531,685 | 996,692 | 14,219,042 | 503,337 |
| Previous Close | 58.80 | 278.39 | 400.16 | 43.70 | 937.61 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 58.94 | 272.33 | 398.46 | 47.46 | 909.64 |
| 20-Day Raw Stochastic | 17.39% | 83.85% | 67.50% | 6.79% | 97.81% |
| 20-Day Relative Strength | 61.06% | 72.54% | 47.72% | 28.70% | 58.01% |
| Weighted Alpha | -3.70 | +34.51 | +14.63 | -36.85 | +25.86 |
| Today's Opinion | 88% Buy | 24% Buy | 8% Buy | 100% Sell | 72% Buy |
| Previous Opinion | 88% Buy | 16% Sell | 8% Buy | 88% Sell | 48% Buy |
| Last Month's Opinion | 100% Buy | 24% Sell | 24% Buy | 8% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.98% since 01/12/24 | +15.79% since 04/26/24 | +1.08% since 04/26/24 | -2.12% since 04/26/24 | +7.83% since 04/26/24 |
| Low | 58.54 on 01/22/24 | 268.99 on 04/29/24 | 391.70 on 04/30/24 | 43.33 on 05/02/24 | 883.20 on 04/29/24 |
| High | 59.27 on 01/16/24 | 322.60 on 05/03/24 | 406.95 on 05/01/24 | 45.38 on 04/29/24 | 954.10 on 05/03/24 |
| 1-Month | |||||
| %Chg | -0.41% since 12/22/23 | +13.91% since 04/03/24 | -1.72% since 04/03/24 | -15.87% since 04/03/24 | +0.15% since 04/03/24 |
| Low | 58.54 on 01/22/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 59.46 on 01/12/24 | 322.60 on 05/03/24 | 412.64 on 04/04/24 | 52.08 on 04/04/24 | 962.20 on 04/04/24 |
| 3-Month | |||||
| %Chg | +5.42% since 10/20/23 | -3.28% since 02/02/24 | -5.39% since 02/02/24 | -9.87% since 02/02/24 | +0.76% since 02/02/24 |
| Low | 55.14 on 10/27/23 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 59.46 on 01/12/24 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +87.48% since 07/21/23 | +15.84% since 11/03/23 | +6.80% since 11/03/23 | -16.89% since 11/03/23 | +16.58% since 11/03/23 |
| Low | 27.30 on 08/08/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 43.33 on 05/02/24 | 783.57 on 11/10/23 |
| High | 64.41 on 10/06/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,117,688 | 149,321,728 | 103,424,960 | 88,584,272 | 102,913,952 |
| Shares Outstanding, K | 70,148 | 536,376 | 258,459 | 2,027,100 | 109,762 |
| Annual Sales | 12,440,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 13,117,200,000 |
| Annual Net Income | -740,870,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 3,953,600,000 |
| Last Quarter Sales | 16,400,000 | 8,196,000,000 | 2,517,700,000 | 11,865,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -161,900,000 | 767,000,000 | 968,800,000 | -11,911,000,000 | 1,159,600,000 |
| 60-Month Beta | 0.77 | 0.60 | 0.39 | 0.45 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.49 on 11/06/23 | 3.96 on 05/02/24 | 4.20 on 02/05/24 | -4.40 on 04/25/24 | 9.55 on 05/02/24 |
| Latest Earnings Date | 02/27/24 | 05/02/24 | 05/06/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | 0.600 on 04/04/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | 04/04/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.87 | 29.92 | 42.10 | 24.04 |